Cervical cancer: open trials in Israel

3 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT07216703
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hillel Yaffe Medical Center (Site 1903), Hadera · Rambam Health Care Campus (Site 1907), Haifa · Carmel Hospital (Site 1901), Haifa · Shaare Zedek Medical Center (Site 1905), Jerusalem · Rabin Medical Center (Site 1904), Petah Tikva · Sourasky Medical Center (Site 1902), Tel Aviv
Registry updated 2026-11-06
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Rambam Health Care Campus, Haifa · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Ramat Gan · Sourasky Medical Center, Tel Aviv
Registry updated 2026-08-17
NCT06196190
Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer
Research · Rambam Health Care Campus
Rambam Health Care Center, Haifa
Registry updated 2024-01-09

This page is not medical advice. Talk to your doctor before contacting a trial.

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)